Viewing StudyNCT05849480



Ignite Creation Date: 2024-05-06 @ 6:57 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05849480
Status: RECRUITING
Last Update Posted: 2024-06-05
First Post: 2023-05-08

Brief Title: A Study of CDX-1140 a CD40 Agonist in Combination With Capecitabine and Oxaliplatin CAPOX and Keytruda in Subjects With Biliary Tract Carcinoma BTC
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Biliary Cancer
Bile Duct Cancer
Cancer of the Bile Duct
Keywords:
Name View
CD40 agonist View
Immunotherapy View
Pembrolizumab View
CAPOX View
CDX-1140 View